CellCept (mycophenolate mofetil) is a prescription drug used to prevent organ rejection following certain organ transplants. The drug comes in oral forms and as a liquid solution for injection. It’s ...
CellCept can cause certain side effects, some of which are more common than others. These side effects may be temporary, lasting a few days to weeks. However, if the side effects last longer than that ...
19 May 2004, Basel, Switzerland – New data presented this week in over 70 abstracts at the American Transplant Congress in Boston, USA strengthen even further the body of evidence that CellCept® ...
Credit: Getty Images. The expanded approval was based on pediatric extrapolation of efficacy from adequate and well-controlled studies and pharmacokinetic data in adult heart transplant and liver ...
TORONTO, June 4 /PRNewswire/ -- The 12-month results from a multicenter trial monitoring CellCept(R) (mycophenolate mofetil) in combination with calcineurin inhibitors (CNIs) in renal transplantation ...
Boston, May 16, 2004 - Data presented today at a top U.S. transplant meeting demonstrated better patient and graft (organ) survival in liver and kidney transplant patients taking CellCept® ...
Mycophenolate mofetil 200mg/mL; pwd for oral susp after reconstitution; mixed fruit flavor; contains phenylalanine. Store dry powder at 25°C (77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) ...
Please provide your email address to receive an email when new articles are posted on . After 10 years of follow-up, CellCept was not shown to be superior to azathioprine for the treatment of lupus ...
June 9, 2006 — The U.S. Food and Drug Administration (FDA) has approved orphan drug status for mycophenolate mofetil in the treatment of pemphigus vulgaris; second-generation antisense drug for the ...
The FDA is warning doctors and patients that CellCept, a drug for organ transplant patients, can cause miscarriages and birth defects. Made by Roche, CellCept will get a "black box" warning that it's ...
CellCept (mycophenolate mofetil) is a brand-name drug that’s prescribed to help prevent organ rejection after a transplant in adults and some children. CellCept comes in several forms. The dosage can ...
CellCept (mycophenolate mofetil) is a prescription drug that’s used to help prevent organ rejection after an organ transplant. The most common side effects reported with CellCept include diarrhea and ...